CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 105 enrolled
Drug / intervention
Acidform 5 g +3 moredrug
Likely dose
Acidform 5 gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02693418
NCT02693418Phase 1Completed

A Randomized, Placebo Controlled Pilot Study to Determine the Effect and Duration of Acidform Gel on Vaginal pH

Evofem Inc.·interventional·Posted Feb 26, 2016·Updated Nov 20, 2020

In Brief

A Phase 1 clinical trial evaluating Acidform 5 g, Placebo 4 g, and 2 other interventions for Healthy. Completed, enrolled 105 participants across 2 sites.

Detailed Summary

The objective of this study was to determine the magnitude and duration of the reduction in pH (acidification) following a single dose of Acidform vaginal gel containing 3, 4, or 5 g compared with hydroxyethylcellulose placebo gel (4 g) or no treatment. Vaginal pH was measured 1 h, 6 h, 12 h, 24 h, then once daily for 7 days. In addition, the participants were assessed for an exploratory endpoint to the determine effect of one dose of Acidform gel (3, 4 or 5 g) or placebo gel (4 g) or no treatment, on asymptomatic bacterial vaginosis (BV).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States

Timeline

Phase 1CompletedFinished
20162017201820192020202120222023202420252026
First PostedFeb 26, 2016
Enrollment StartAug 24, 2016
Primary CompletionDec 12, 2016
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 10.3 years ago

Interventions

Acidform 5 gdrug

Effect of 5 g vaginally administered Acidform on pH over 7 days

Placebo 4 gdrug

Effect of 4 g of vaginally administered HEC placebo gel on pH over 7 days

Acidform 4 gdrug

Effect of 4 g vaginally administered Acidform on pH over 7 days

Acidform 3 gdrug

Effect of 3 g vaginally administered Acidform on pH over 7 days